Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ARS Pharmaceuticals, Inc. | 875,000 | reported | 02 Jan 2026 | tx 107+20,919,127−4,510,285 |
| CADENCE PHARMACEUTICALS INC | 25,000 | reported | 22 Mar 2007 | tx 1+25,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 240,000 | 0.00 USD | deriv |
| 02 Jan 2026 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 875,000 | 0.00 USD | deriv |
| 21 Aug 2025 | SALE | ARS Pharmaceuticals, Inc. | 50,000 | 14.49 USD | |
| 02 Jan 2025 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 261,900 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 767,600 | 0.00 USD | deriv |
| 17 Dec 2024 | SALE | ARS Pharmaceuticals, Inc. | 50,000 | 11.67 USD | |
| 17 Dec 2024 | SALE | ARS Pharmaceuticals, Inc. | 50,000 | 11.67 USD | |
| 10 Dec 2024 | SALE | ARS Pharmaceuticals, Inc. | 50,000 | 13.16 USD | |
| 10 Dec 2024 | SALE | ARS Pharmaceuticals, Inc. | 50,000 | 13.17 USD | |
| 06 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 11,876 | 8.42 USD | |
| 06 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 13,789 | 1.44 USD | |
| 06 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 11,876 | 8.42 USD | |
| 06 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 11,876 | 0.00 USD | deriv |
| 06 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 13,789 | 0.00 USD | deriv |
| 06 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 11,876 | 0.00 USD | deriv |
| 19 Nov 2024 | SALE | ARS Pharmaceuticals, Inc. | 50,000 | 13.95 USD | |
| 19 Nov 2024 | SALE | ARS Pharmaceuticals, Inc. | 50,000 | 13.95 USD | |
| 12 Nov 2024 | SALE | ARS Pharmaceuticals, Inc. | 45,045 | 16.76 USD | |
| 12 Nov 2024 | SALE | ARS Pharmaceuticals, Inc. | 4,955 | 17.64 USD | |
| 12 Nov 2024 | SALE | ARS Pharmaceuticals, Inc. | 45,124 | 16.76 USD | |
| 12 Nov 2024 | SALE | ARS Pharmaceuticals, Inc. | 4,876 | 17.64 USD | |
| 15 Oct 2024 | SALE | ARS Pharmaceuticals, Inc. | 1,450 | 15.25 USD | anomaly |
| 15 Oct 2024 | SALE | ARS Pharmaceuticals, Inc. | 50,000 | 14.88 USD | |
| 15 Oct 2024 | SALE | ARS Pharmaceuticals, Inc. | 48,550 | 14.86 USD | |
| 08 Oct 2024 | SALE | ARS Pharmaceuticals, Inc. | 50,000 | 13.83 USD |